{"database": "lobbying", "table": "lobbying_activities", "rows": [[2814328, "ee6c27ca-e12b-485b-a390-73bcf8b5722c", "Q2", "I STREET ADVOCATES", 51753, "USAGAINSTALZHEIMER'S", 2022, "second_quarter", "HCR", "The Concentrating on High-Value Alzheimers Needs to Get to an End Act of 2021 (CHANGE Act) HR 3354/S 1692; Alzheimer's appropriation's at NIH and CDC and HHS; The NAPA Reauthorization Act, S. 4203.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2022-07-05T10:54:46-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2814328"], "units": {}, "query_ms": 0.29811798594892025, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}